Christopher Chitambar

Professor

Medical College of Wisconsin
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Professor Christopher Chitambar is a faculty member at the Medical College of Wisconsin, located in the United States. His research primarily focuses on interventions for patients with cancer, specifically exploring the feasibility of diet and exercise programs during breast cancer treatment. His work aims to enhance patient care and outcomes during radiotherapy.

Articles (7)

Year:

2026

Year:

2026

Year:

2024

FitBit activity levels. Percent change in average total steps per day ( A ), average total active minutes per day ( B ), and average active minutes per day ( C ) in the intervention group compared with their baselines. Total steps per day ( D ), total active minutes per day ( E ), and total very active minutes per day ( F ) during the baseline week in the intervention and control groups. Graphs show mean ± SE. *, P

Year:

2024

Purpose: Among patients with breast cancer undergoing radiotherapy, posttreatment cardiovascular disease and worsened quality of life (QoL) are leading causes of morbidity and mortality. To overcome these negative radiotherapy effects, this prospective, randomized clinical trial pilots a 12-week Stay on Track exercise and diet intervention for overweight patients with nonmetastatic breast cancer undergoing whole-breast radiotherapy. Experimental Design: The intervention group ( n = 22) participated in three personal exercise and dietary counseling sessions, and received three text reminders/week to adhere to recommendations. The control group ( n = 22) was administered a diet/exercise information binder. All patients received a Fitbit, and at baseline, 3 months, and 6 months, measurements of biomarkers, dual-energy X-ray absorptiometry scans, QoL and physical activity surveys, and food frequency questionnaires were obtained. A satisfaction survey was administered at 3 months. Results: Stay on Track was well received, with high rates of adherence and satisfaction. The intervention group showed an increase in self-reported physical activity and preserved QoL, a decrease in body mass index and visceral fat, and higher American Cancer Society/American Institute of Cancer Research dietary adherence. The control participants had reduced QoL, anti-inflammatory markers, and increased metabolic syndrome markers. Both groups had decreased overall body mass. These changes were within group effects. When comparing the intervention and control groups over time, there were notable improvements in dietary adherence in the intervention group. Conclusions: Targeted lifestyle interventions during radiotherapy are feasible and could decrease cardiovascular comorbidities in patients with breast cancer. Larger-scale implementation with longer follow-up can better determine interventions that influence cardiometabolic health and QoL. Significance: This pilot study examines cardiometabolic benefits of a combined diet and exercise intervention for patients with breast cancer undergoing radiotherapy. The intervention included an activity tracker (FitBit) and text message reminders to promote adherence to lifestyle interventions. Large-scale implementation of such programs may improve cardiometabolic outcomes and overall QoL among patients with breast cancer.

Year:

2024

FitBit activity levels. Percent change in average total steps per day ( A ), average total active minutes per day ( B ), and average active minutes per day ( C ) in the intervention group compared with their baselines. Total steps per day ( D ), total active minutes per day ( E ), and total very active minutes per day ( F ) during the baseline week in the intervention and control groups. Graphs show mean ± SE. *, P

Year:

2024

Purpose: Among patients with breast cancer undergoing radiotherapy, posttreatment cardiovascular disease and worsened quality of life (QoL) are leading causes of morbidity and mortality. To overcome these negative radiotherapy effects, this prospective, randomized clinical trial pilots a 12-week Stay on Track exercise and diet intervention for overweight patients with nonmetastatic breast cancer undergoing whole-breast radiotherapy. Experimental Design: The intervention group ( n = 22) participated in three personal exercise and dietary counseling sessions, and received three text reminders/week to adhere to recommendations. The control group ( n = 22) was administered a diet/exercise information binder. All patients received a Fitbit, and at baseline, 3 months, and 6 months, measurements of biomarkers, dual-energy X-ray absorptiometry scans, QoL and physical activity surveys, and food frequency questionnaires were obtained. A satisfaction survey was administered at 3 months. Results: Stay on Track was well received, with high rates of adherence and satisfaction. The intervention group showed an increase in self-reported physical activity and preserved QoL, a decrease in body mass index and visceral fat, and higher American Cancer Society/American Institute of Cancer Research dietary adherence. The control participants had reduced QoL, anti-inflammatory markers, and increased metabolic syndrome markers. Both groups had decreased overall body mass. These changes were within group effects. When comparing the intervention and control groups over time, there were notable improvements in dietary adherence in the intervention group. Conclusions: Targeted lifestyle interventions during radiotherapy are feasible and could decrease cardiovascular comorbidities in patients with breast cancer. Larger-scale implementation with longer follow-up can better determine interventions that influence cardiometabolic health and QoL. Significance: This pilot study examines cardiometabolic benefits of a combined diet and exercise intervention for patients with breast cancer undergoing radiotherapy. The intervention included an activity tracker (FitBit) and text message reminders to promote adherence to lifestyle interventions. Large-scale implementation of such programs may improve cardiometabolic outcomes and overall QoL among patients with breast cancer.

Year:

2024

Collaborators (5)

Aniko Szabo

-

UNITED STATES
View details

Carmen Bergom

Associate Professor

Washington University in St. Louis

UNITED STATES
View details

Melinda Stolley

Professor

Medical College of Wisconsin

UNITED STATES
View details

Lindsay L. Peterson

Washington University School of Medicine

UNITED STATES
View details

Adam Currey

Professor

Medical College of Wisconsin

UNITED STATES
View details